Follow Our Live Coverage of COVID-19 Developments

Drug Makers Challenge New Rule Requiring Drug Prices in TV Ads

Lawsuit against the rule filed Friday by Merck, Eli Lilly, and Amgen

Please note: This article was published more than one year ago. The facts and conclusions presented may have since changed and may no longer be accurate. And "More information" links may no longer work. Questions about personal health should always be referred to a physician or other health care professional.

MONDAY, June 17, 2019 (HealthDay News) -- Three large drug makers have launched a legal challenge against the Trump administration's rule requiring the prices of drugs to be included in television ads.

A lawsuit against the rule, set to take effect July 9, was filed Friday in federal court in Washington, D.C., by Merck, Eli Lilly, and Amgen, The New York Times reported. A trade group for advertisers is also part of the lawsuit.

The lawsuit contends that the rule is illegal because it violates the companies' First Amendment rights and claims that the pricing information could mislead consumers because insurers often cover most of a drug's cost, The Times reported.

The rule applies to any drug with a list price of more than $35 a month.

The New York Times Article

Last Updated: